News about advances in research and treatment related to vision loss can come at us in quantities that are not only abundant, but also quite redundant. Here is a selection of noteworthy developments reported in 2024. We’ll be watching for interesting topics to add and progress to share.
- Glaucoma Implant
FDA Approves First-of-its-Kind Glaucoma Treatment
BrightFocus Foundation
The iDose TR, is implanted in the eye to automatically deliver glaucoma medicine consistently for up to 3 years. The device replaces the need for manually administered eye drops. Learn More
- Retinal Implant
Science Announces Positive Preliminary Results For Vision Restoration In Pivotal Clinical Trial
Science Corporation
Science Corporation introduced the Prima implant, an advanced retinal device that has shown promising results in restoring vision for individuals with geographic atrophy, a form of age-related macular degeneration (AMD). Clinical trials reported significant improvements in visual acuity among participants. Learn More
- Stargardt Pill
Daily tablet Shows Promise as First Treatment for Stargardt Disease
Macular Society
The drug, gildeuretinol (ALK-001), has shown the potential to slow disease progression by more than 20% during the 2 year phase 1 & 2 clinical trials. Based on these results the drug appears to be on fast track for FDA approval. Learn More
Insert Image: https://elements.envato.com/vision-eye-exam-and-healthcare-with-a-doctor-woman-SB2H9JF
Caption/Alt-text: Research doctor examines older man’s eyes
- Falls Prevention
Link Between Eye Examinations and Fall Prevention in Older Adults
American Optometric Association
Studies highlight that individuals with eye conditions such as cataracts, age-related macular degeneration (AMD), and glaucoma have a higher risk of falls and fractures. This underscores the importance of integrating fall prevention strategies into eye care for affected patients. Learn More
- Macular Degeneration
Scientists Get Closer to Stopping Macular Degeneration
US News & World Report
Age-related macular degeneration is the leading cause of vision loss in people over 50. Treatments currently available slow the inevitable progression of the disease, but none actually halt it. Researchers have just discovered a protein that might possibly change that. Learn More